相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Extended follow-up of a phase 3 trial in relapsed multiple myeloma:: final time-to-event results of the APEX trial
Paul G. Richardson et al.
BLOOD (2007)
Reversal of acute renal failure by bortezomib-based chemotherapy in patients with multiple myeloma
Heinz Ludwig et al.
HAEMATOLOGICA (2007)
Activity and safety of bortezomib in multiple myeloma patients with advanced renal failure: a multicenter retrospective study
Asher A. Chanan-Khan et al.
BLOOD (2007)
Multiple myeloma in end-stage renal disease
Jeffrey G. Penfield
SEMINARS IN DIALYSIS (2006)
United States Food and Drug Administration approval summary: Bortezomib for the treatment of progressive multiple myeloma after one prior therapy
Robert C. Kane et al.
CLINICAL CANCER RESEARCH (2006)
Bortezomib and dexamethasone in previously untreated multiple myeloma associated with renal failure and reversal of renal failure
Ashok Kumar Malani et al.
ACTA HAEMATOLOGICA (2006)
Early mortality after diagnosis of multiple myeloma: Analysis of patients entered onto the United Kingdom Medical Research Council trials between 1980 and 2002 - Medical Research Council Adult Leukaemia Working Party
BM Augustson et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Autologous stem cell transplantation in multiple myeloma: outcome in patients with renal failure
LM Knudsen et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2005)
Bortezomib or high-dose dexamethasone for relapsed multiple myeloma
PG Richardson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
International staging system for multiple myeloma
PR Greipp et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Melphalan 200 mg/m2 with blood stem cell support as first-line myeloma therapy:: impact of glomerular filtration rate on engraftment, transplantation-related toxicity and survival
K Carlson
BONE MARROW TRANSPLANTATION (2005)
Bortezornib in recurrent and/or refractory multiple myeloma - Initial clinical experience in patients with impaired renal function
S Jagannath et al.
CANCER (2005)
Renal, hematologic and infectious complications in multiple myeloma
J Blade et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2005)
Drug therapy: Multiple myeloma
RA Kyle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Multicenter phase 2 trial of thalidomide in relapsed/refractory multiple myeloma: adverse prognostic impact of advanced age
L Mileshkin et al.
BLOOD (2003)
Renal failure in multiple myeloma: reversibility and impact on the prognosis
LM Knudsen et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2000)
Renal involvement in multiple myeloma: A 10-year study
V Sakhuja et al.
RENAL FAILURE (2000)